Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]

Association of gene expression with clinical outcomes in RCC patients treated...

Prof Scott Tykodi - University of Washington, Seattle, USA

Association of gene expression with clinical outcomes in RCC patients treated with pembrolizumab ( Prof Scott Tykodi - University of Washington, Seattle, USA )

Renal cell cancer: Highlights from ASCO 2020

Prof Scott Tykodi - University of Washington, Seattle, USA

Renal cell cancer: Highlights from ASCO 2020 ( Prof Scott Tykodi - University of Washington, Seattle, USA )

FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment...

Prof Scott Tykodi - University of Washington, Seattle, USA

$FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory advanced renal cell carcinoma ( Prof Scott Tykodi - University of Washington, Seattle, USA )$

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer ( Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan )

Evaluating the impact of daratumumab for the treatment of multiple myeloma...

Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA

Evaluating the impact of daratumumab for the treatment of multiple myeloma according to cytogenetic risk ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )

MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD...

Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA

MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD response-adapted consolidation in NDMM ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )

Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with...

Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA

$Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL ( Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA )$

IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial...

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA

IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )

Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC

Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )

Using the novel antibody-drug conjugate, loncastuximab tesirine to treat...

Prof Carmelo Carlo-Stella - Humanitas Cancer Center, Milan, Italy

Using the novel antibody-drug conjugate, loncastuximab tesirine to treat patients with R/R diffuse large B-cell lymphoma ( Prof Carmelo Carlo-Stella - Humanitas Cancer Center, Milan, Italy )

Treating patients with multiple myeloma in the real world

Dr Ajai Chari and Prof Roman Hájek

Treating patients with multiple myeloma in the real world ( Dr Ajai Chari and Prof Roman Hájek )

ASCEND final results: Acalabrutinib vs idelalisib plus rituximab or...

Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy

ASCEND final results: Acalabrutinib vs idelalisib plus rituximab or bendamustine plus rituximab in R/R CLL ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )

More from ecancer